EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Renal Function Is Associated with Changes in Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Denosumab: Data From a Retrospective Cohort Study

Antonino Catalano iD, Cecilia Oliveri iD, Giuseppe Natale, Rita Maria Agostino, Giovanni Squadrito, Agostino Gaudio iD, Guido Gembillo iD, Djordje Marina, Valeria Cernaro iD, Elisa Longhitano iD, Giorgio Basile, Nunziata Morabito und 1 weitere

Journal of Clinical Medicine · 19.10.2024 · 13 (20) · 6239

DOI: 10.3390/jcm13206239 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.10.2024. Verfasst von Antonino Catalano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Unit and School of Geriatrics, Department of Clinical and Experimental Medicine, University of Messina, Policlinico "G. Martino", 98124 Messina, Ital…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Renal function influences bone metabolism, as kidney failure can increase the risk of fractures. Denosumab is an approved osteoporosis treatment, but its efficacy in relation to renal function has not yet been studied in real-life scenarios. This study aimed to investigate the denosumab-induced change in bone mineral density (BMD) according to kidney function.

Methods

A retrospective analysis was conducted at the outpatient clinic in postmenopausal women receiving denosumab (60 mg subcutaneously administered every 6 months). The glomerular filtration rate (eGFR) was measured by the 2021 CKD-EPI equation and patients were stratified for eGFR categories. BMD was measured by dual-energy X-ray absorptiometry.

Results

128 women (mean age 70.3 ± 9.4 years) were recruited. The mean denosumab treatment duration was 3.9 ± 1.4 years and all the participants had improved BMD values. In stepwise multiple regression analysis—after controlling for age, BMI, and treatment duration—the eGFR value (ß = −0.11, SE 0.04, p = 0.01) was independently associated with the lumbar spine BMD change. The same association remained when the eGFR categories were considered (ß = 3.564, SE 1.29, p = 0.007). In addition, after controlling for BMI and the duration of denosumab treatment, age (ß = −0.7915, SE 0.37, p = 0.03) and eGFR (ß = −0.3257, SE 0.1567, p = 0.04) were found to be associated with femoral neck BMD change. The association remained when considering eGFR categories (ß = 8.7339, SE 4.29, p = 0.04).

Conclusions

This retrospective study suggests that eGFR is associated with denosumab efficacy in postmenopausal women treated for osteoporosis.

Schlagwörter

Stichwörter der Autor:innen

bone mineral densitydenosumabglomerular filtration rateosteoporosispostmenopauserenal function

Autor:innen und Institutionen

  • Unit and School of Geriatrics, Department of Clinical and Experimental Medicine, University of Messina, Policlinico "G. Martino", 98124 Messina, Italy.
  • Mineral Metabolism and Nephrology Clinic of Vibo Valentia Hospital, 89900 Vibo Valentia, Italy.
  • Unit of Oncology, Grand Metropolitan Hospital "Bianchi Melacrino Morelli", 89133 Reggio Calabria, Italy.
  • Unit and School of Internal Medicine, Department of Clinical and Experimental Medicine, University of Messina, 98124 Messina, Italy.
  • Unit and School of Internal Medicine, Department of Clinical and Experimental Medicine, University of Catania, Policlinico "G. Rodolico", 95123 Catania, Italy.
  • Unit and School of Nephrology, Policlinico "G. Martino", Department of Clinical and Experimental Medicine, University of Messina, 98124 Messina, Italy.

ORCID-Profile: Antonino Catalano, Cecilia Oliveri, Agostino Gaudio, Guido Gembillo, Valeria Cernaro, Elisa Longhitano

Zitieren

APA

Catalano, A., Oliveri, C., Natale, G., Agostino, R. M., Squadrito, G., Gaudio, A., Gembillo, G., Marina, D., Cernaro, V., Longhitano, E., Basile, G., Morabito, N., & Santoro, D. (2024). Renal Function Is Associated with Changes in Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Denosumab: Data From a Retrospective Cohort Study. Journal of Clinical Medicine, 13(20), 6239. https://doi.org/10.3390/jcm13206239

Vancouver

Catalano A, Oliveri C, Natale G, Agostino RM, Squadrito G, Gaudio A, et al. Renal Function Is Associated with Changes in Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Denosumab: Data From a Retrospective Cohort Study. Journal of Clinical Medicine. 2024;13(20):6239. doi:10.3390/jcm13206239

BibTeX
@article{Catalano2024,
  author = {Catalano, Antonino and Oliveri, Cecilia and Natale, Giuseppe and Agostino, Rita Maria and Squadrito, Giovanni and Gaudio, Agostino and Gembillo, Guido and Marina, Djordje and Cernaro, Valeria and Longhitano, Elisa and Basile, Giorgio and Morabito, Nunziata and Santoro, Domenico},
  title = {Renal Function Is Associated with Changes in Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Denosumab: Data From a Retrospective Cohort Study},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {20},
  pages = {6239},
  doi = {10.3390/jcm13206239}
}
Kostenlos starten →